Search
for
Sort by
Research 961–990 of 1000+
- Relationship between Copper, Zinc, and Copper-to-Zinc Ratio in Hair and Severity of Coronary Artery Disease according to the SYNTAX Score
- Teledermatology in the COVID-19 pandemic: A systematic review
- Part I: Accuracy of Teledermatology in Inflammatory Dermatoses
- COVID-19: A catalyst for innovative hybrid teledermatology workflows to increase access and improve patient care at a large group practice
- Guidelines for the Management of Tinea Capitis in Children
- Tinea Capitis: An Updated Review
- Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art
- Platelet-rich plasma for the treatment of androgenetic alopecia: A patient survey
- Benign Mucous Membrane Pemphigoid
- Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study
- Evaluation of Serum Homocysteine, High-Sensitivity CRP, and RBC Folate in Patients with Alopecia Areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- COVID-19 and Sex Differences
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- A Guide to Assessing Damage Response Pathways of the Hair Follicle: Lessons From Cyclophosphamide-Induced Alopecia in Mice
- Defining hirsutism in Chinese women: a cross-sectional study
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Alopecia areata: An update
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients